Literature DB >> 8227343

Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.

S Dinneen1, A Alzaid, J Miles, R Rizza.   

Abstract

Glucocorticoid concentrations vary throughout the day. To determine whether an increase in cortisol similar to that present during sleep is of physiologic significance in humans, we studied the disposition of a mixed meal when the nocturnal rise in cortisol was mimicked or prevented using metyrapone plus either a variable or constant hydrocortisone infusion. When glucose concentrations were matched with a glucose infusion, hepatic glucose release (2.6 +/- 0.2 vs. 1.5 +/- 0.4 nmol/kg per 6 h) was higher (P < 0.05) while glucose disappearance (5.9 +/- 0.3 vs. 7.3 +/- 0.9 mmol/kg per 6 h) and forearm arteriovenous glucose difference (64 +/- 24 vs. 231 +/- 62 mmol/dl per 6 h) were lower (P < 0.05) during the variable than basal infusion. The greater hepatic response during the variable cortisol infusion was mediated (at least in part) by inhibition of insulin and stimulation of glucagon secretion as reflected by lower (P < 0.05) C-peptide (0.29 +/- 0.01 vs. 0.38 +/- 0.04 mmol/liter per 6 h) and higher (P < 0.05) glucagon (42.7 +/- 2.0 vs. 39.3 +/- 1.8 ng/ml per 6 h) concentrations. In contrast, the decreased rates of glucose uptake appeared to result from a state of "physiologic" insulin resistance. The variable cortisol infusion also increased (P < 0.05) postprandial palmitate appearance as well as palmitate, beta-hydroxybutyrate, and alanine concentrations, suggesting stimulation of lipolysis, ketogenesis, and proteolysis. We conclude that the circadian variation in cortisol concentration is of physiologic significance in normal humans.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227343      PMCID: PMC288409          DOI: 10.1172/JCI116832

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  62 in total

Review 1.  Carbohydrate metabolism in non-insulin-dependent diabetes mellitus.

Authors:  S Dinneen; J Gerich; R Rizza
Journal:  N Engl J Med       Date:  1992-09-03       Impact factor: 91.245

2.  Pathways of carbon flux in gluconeogenesis.

Authors:  J T Brosnan
Journal:  Fed Proc       Date:  1982-01

3.  Failure of cortisol blockade to inhibit early morning increases in basal insulin requirements in fasting insulin-dependent diabetics.

Authors:  G M Bright; T W Melton; A D Rogol; W L Clarke
Journal:  Diabetes       Date:  1980-08       Impact factor: 9.461

4.  The effect of glucocorticoids on the insulin receptor: an in vivo and in vitro study.

Authors:  I G Fantus; J Ryan; N Hizuka; P Gorden
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

5.  Relationship between the plasma glucose level and glucose uptake in the conscious dog.

Authors:  A D Cherrington; P E Williams; M S Harris
Journal:  Metabolism       Date:  1978-07       Impact factor: 8.694

6.  Reversal of steroid-induced insulin resistance by a nicotinic-acid derivative in man.

Authors:  A Ekstrand; C Saloranta; J Ahonen; C Grönhagen-Riska; L C Groop
Journal:  Metabolism       Date:  1992-07       Impact factor: 8.694

7.  A simplified, colorimetric micromethod for xylose in serum or urine, with phloroglucinol.

Authors:  T J Eberts; R H Sample; M R Glick; G H Ellis
Journal:  Clin Chem       Date:  1979-08       Impact factor: 8.327

8.  Studies on hepatic glucose cycles in normal and methylprednisolone-treated dogs.

Authors:  B Issekutz
Journal:  Metabolism       Date:  1977-02       Impact factor: 8.694

9.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

Authors:  R A Rizza; L J Mandarino; J E Gerich
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

10.  Effects of prednisolone and dexamethasone in vivo and in vitro: studies of insulin binding, deoxyglucose uptake and glucose oxidation in rat adipocytes.

Authors:  R De Pirro; A Green; M Y Kao; J M Olefsky
Journal:  Diabetologia       Date:  1981-08       Impact factor: 10.122

View more
  45 in total

1.  Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males.

Authors:  Daniel J Lesser; Rajeev Bhatia; Winston H Tran; Flavia Oliveira; Ricardo Ortega; Thomas G Keens; Steven D Mittelman; Michael C K Khoo; Sally L Davidson Ward
Journal:  Pediatr Res       Date:  2012-06-05       Impact factor: 3.756

2.  Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids.

Authors:  F Delaunay; A Khan; A Cintra; B Davani; Z C Ling; A Andersson; C G Ostenson; J Gustafsson; S Efendic; S Okret
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Adverse metabolic and cardiovascular consequences of circadian misalignment.

Authors:  Frank A J L Scheer; Michael F Hilton; Christos S Mantzoros; Steven A Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

4.  Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics.

Authors:  Xuewen Wang; Faidon Magkos; Bruce W Patterson; Dominic N Reeds; Janine Kampelman; Bettina Mittendorfer
Journal:  Eur J Endocrinol       Date:  2012-05-22       Impact factor: 6.664

5.  Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance.

Authors:  Arlet V Nedeltcheva; Lynn Kessler; Jacqueline Imperial; Plamen D Penev
Journal:  J Clin Endocrinol Metab       Date:  2009-06-30       Impact factor: 5.958

6.  Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans.

Authors:  Christopher J Morris; Jessica N Yang; Joanna I Garcia; Samantha Myers; Isadora Bozzi; Wei Wang; Orfeu M Buxton; Steven A Shea; Frank A J L Scheer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

Review 7.  Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation.

Authors:  Kevin G Burfeind; Vijayshree Yadav; Daniel L Marks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-11       Impact factor: 5.081

Review 8.  Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment.

Authors:  Corey J Leinum; John M Dopp; Barbara J Morgan
Journal:  Nutr Clin Pract       Date:  2009-12       Impact factor: 3.080

9.  Failure of glucagon suppression contributes to postprandial hyperglycaemia in IDDM.

Authors:  S Dinneen; A Alzaid; D Turk; R Rizza
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

Review 10.  11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes.

Authors:  T M Stulnig; W Waldhäusl
Journal:  Diabetologia       Date:  2003-12-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.